drugset / Trial / NCT05501704
ETHAN - ET for Male BC
Phase 2
Recruiting
60 enrolled
Jose Pablo Leone
Eli Lilly and Company · collabTranslational Breast Cancer Research Consortium (TBCRC) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen is the most effective treatment for male breast cancer. The drugs used in this study are: * Tamoxifen * Anastrozole * Degarelix * Abemaciclib
Timeline
- Start
- 2023-10-11
- Primary completion
- 2027-04-01
- Completion
- 2036-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abemaciclib | Small molecule | — | Oral |
| Subject | Anastrozole | Other / unclassified | — | Oral |
| Subject | Degarelix | Other / unclassified | — | Subcutaneous |
| Subject | Tamoxifen | Small molecule | — | Oral |